---
title: "Time-of-Day Specified Ipilimumab and Nivolumab for the Treatment of Stage IV Unresectable Melanoma, The TIME Trial"
date: "2025-09-04T04:00:00.000Z"
publishedDate: "4 septembre 2025"
summary: "Conditions : Advanced Acral Melanoma; Advanced Cutaneous Melanoma; Advanced Mucosal Melanoma; Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Acral Melanoma; Metastatic Cutaneous Melanoma; Metastatic Mucosal Melanoma; Unresectable Acral Melanoma; Unresectable Cutaneous Melanoma; Unresectable Mucosal Melanoma Interventions : Procedure: Biopsy Procedure; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Biological: Ipilimumab; Procedure: Magnetic Resonance Imaging; Other: Medical Device Usage and Evaluation; Biological: Nivolumab; Other: Questionnaire Administration Sponsors : Emory University; National Cancer Institute (NCI) Not yet recruiting"
importance: ""
sourceUrl: "https://clinicaltrials.gov/study/NCT07155317?term=interventional+radiology&aggFilters=status%3A"
tags: ["France", "Actualité", "ClinicalTrials.gov — ta recherche"]
permalink: "/papers/2025-09-04-time-of-day-specified-ipilimumab-and-nivolumab-for-the-treatment-of-stage-iv-unresectable-melanoma-the-time-trial"
imageUrl: ""
imageCredit: ""
---

## L’essentiel

Conditions : Advanced Acral Melanoma; Advanced Cutaneous Melanoma; Advanced Mucosal Melanoma; Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Acral Melanoma; Metastatic Cutaneous Melanoma; Metastatic Mucosal Melanoma; Unresectable Acral Melanoma; Unresectable Cutaneous Melanoma; Unresectable Mucosal Melanoma Interventions : Procedure: Biopsy Procedure; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Biological: Ipilimumab; Procedure: Magnetic Resonance Imaging; Other: Medical Device Usage and Evaluation; Biological: Nivolumab; Other: Questionnaire Administration Sponsors : Emory University; National Cancer Institute (NCI) Not yet recruiting

## Lien source

https://clinicaltrials.gov/study/NCT07155317?term=interventional+radiology&aggFilters=status%3A
